These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 17461727)
21. Optical pretargeting of tumor with fluorescent MORF oligomers. He J; Rusckowski M; Wang Y; Dou S; Liu X; Zhang S; Liu G; Hnatowich DJ Mol Imaging Biol; 2007; 9(1):17-23. PubMed ID: 17171474 [TBL] [Abstract][Full Text] [Related]
27. Pretargeting vs. direct targeting of human betalox5 islet cells subcutaneously implanted in mice using an anti-human islet cell antibody. Liu G; Dou S; Akalin A; Rusckowski M; Streeter PR; Shultz LD; Greiner DL Nucl Med Biol; 2012 Jul; 39(5):645-51. PubMed ID: 22316614 [TBL] [Abstract][Full Text] [Related]
28. Improving the delivery of radionuclides for imaging and therapy of cancer using pretargeting methods. Sharkey RM; Karacay H; Cardillo TM; Chang CH; McBride WJ; Rossi EA; Horak ID; Goldenberg DM Clin Cancer Res; 2005 Oct; 11(19 Pt 2):7109s-7121s. PubMed ID: 16203810 [TBL] [Abstract][Full Text] [Related]
29. Preparation of (111)In-DTPA morpholino oligomer for low abdominal accumulation. Liu G; Dou S; Rusckowski M; Greiner D; Hnatowich D Appl Radiat Isot; 2010 Sep; 68(9):1709-14. PubMed ID: 20359901 [TBL] [Abstract][Full Text] [Related]
30. Targeting to tumor necrotic regions with biotinylated antibody and streptavidin modified liposomes. Pan H; Han L; Chen W; Yao M; Lu W J Control Release; 2008 Feb; 125(3):228-35. PubMed ID: 18022270 [TBL] [Abstract][Full Text] [Related]
31. Cell studies of a three-component antisense MORF/tat/Herceptin nanoparticle designed for improved tumor delivery. Liu X; Wang Y; Nakamura K; Kubo A; Hnatowich DJ Cancer Gene Ther; 2008 Feb; 15(2):126-32. PubMed ID: 18084241 [TBL] [Abstract][Full Text] [Related]
32. Intraperitoneal injection is not always a suitable alternative to intravenous injection for radiotherapy. Dou S; Smith M; Wang Y; Rusckowski M; Liu G Cancer Biother Radiopharm; 2013 May; 28(4):335-42. PubMed ID: 23469942 [TBL] [Abstract][Full Text] [Related]
33. Comparing the intracellular fate of components within a noncovalent streptavidin nanoparticle with covalent conjugation. Liu Y; Cheng D; Liu X; Liu G; Dou S; Xiao N; Chen L; Rusckowski M; Hnatowich DJ Nucl Med Biol; 2012 Jan; 39(1):101-7. PubMed ID: 21958854 [TBL] [Abstract][Full Text] [Related]
34. Replacing 99mTc with 111In improves MORF/cMORF pretargeting by reducing intestinal accumulation. Liu G; Cheng D; Dou S; Chen X; Liang M; Pretorius PH; Rusckowski M; Hnatowich DJ Mol Imaging Biol; 2009; 11(5):303-7. PubMed ID: 19326173 [TBL] [Abstract][Full Text] [Related]
35. Affinity enhancement bivalent morpholino for pretargeting: initial evidence by surface plasmon resonance. He J; Liu G; Vanderheyden JL; Dou S; Mary R; Hnatowich DJ Bioconjug Chem; 2005; 16(2):338-45. PubMed ID: 15769087 [TBL] [Abstract][Full Text] [Related]
37. Pretargeted radioimmunotherapy in tumored mice using an in vivo 212Pb/212Bi generator. Su FM; Beaumier P; Axworthy D; Atcher R; Fritzberg A Nucl Med Biol; 2005 Oct; 32(7):741-7. PubMed ID: 16243650 [TBL] [Abstract][Full Text] [Related]
38. Trans-cyclooctene tag with improved properties for tumor pretargeting with the diels-alder reaction. Rossin R; van Duijnhoven SM; Läppchen T; van den Bosch SM; Robillard MS Mol Pharm; 2014 Sep; 11(9):3090-6. PubMed ID: 25077373 [TBL] [Abstract][Full Text] [Related]
39. RNA aptamer-conjugated liposome as an efficient anticancer drug delivery vehicle targeting cancer cells in vivo. Baek SE; Lee KH; Park YS; Oh DK; Oh S; Kim KS; Kim DE J Control Release; 2014 Dec; 196():234-42. PubMed ID: 25450401 [TBL] [Abstract][Full Text] [Related]